Collegium Pharmaceutical Inc - Company & Market Research Reports

Collegium Pharmaceutical is a specialty pharmaceutical company developing and commercializing next generation, abuse-deterrent products for patients suffering from chronic pain. The company has developed a novel, patented, abuse-deterrent technology platform, DETERx, which provides extended-release drug delivery. It was formerly known as Collegium Pharmaceuticals and changed its name to Collegium Pharmaceutical in October 2003. Collegium Pharmaceutical was incorporated in 2002 and is headquartered in Canton, Massachusetts.

Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts - Product Thumbnail Image

Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts

  • Report
  • 283 Pages
From
Low Back Pain Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Low Back Pain Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 334 Pages
From
Chronic Back Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Back Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 95 Pages
From
Back Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Back Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 369 Pages
From
Chronic Back Pain - Pipeline Review, H2 2014 - Product Thumbnail Image

Chronic Back Pain - Pipeline Review, H2 2014

  • Report
  • 67 Pages
From
Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022 - Product Thumbnail Image

Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022

  • Report
  • 870 Pages
From
United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development) - Product Thumbnail Image

United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development)

  • Report
  • 77 Pages
From
Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era - Product Thumbnail Image

Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era

  • Report
  • 135 Pages
From
The Global Pain Therapeutics Market, 5th Edition: Market Trends & R&D Insights - Product Thumbnail Image

The Global Pain Therapeutics Market, 5th Edition: Market Trends & R&D Insights

  • Report
  • 536 Pages
From
Cold, Cough, And Sore Throat Remedies - Global Strategic Business Report - Product Thumbnail Image

Cold, Cough, And Sore Throat Remedies - Global Strategic Business Report

  • Report
  • 873 Pages
From
Chronic Pain - Pipeline Review, H2 2016 - Product Thumbnail Image

Chronic Pain - Pipeline Review, H2 2016

  • Report
  • 335 Pages
From
Chronic Pain - Pipeline Review, H1 2016 - Product Thumbnail Image

Chronic Pain - Pipeline Review, H1 2016

  • Report
  • 382 Pages
From
Chronic Pain - Pipeline Review, H2 2015 - Product Thumbnail Image

Chronic Pain - Pipeline Review, H2 2015

  • Report
  • 389 Pages
From
Chronic Pain - Pipeline Review, H1 2015 - Product Thumbnail Image

Chronic Pain - Pipeline Review, H1 2015

  • Report
  • 344 Pages
From
Controlled Release Drug Delivery Market & Pipeline Insight - Product Thumbnail Image

Controlled Release Drug Delivery Market & Pipeline Insight

  • Drug Pipelines
  • 830 Pages
From
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition - Product Thumbnail Image

Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition

  • Report
  • 251 Pages
From
Global Painful Diabetic Neuropathy Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global Painful Diabetic Neuropathy Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
From
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017

  • Report
  • 254 Pages
From
Behavioral Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Behavioral Disorders Drug Development Pipeline Review, 2017

  • Report
  • 113 Pages
From
Allergy Drugs - Global Strategic Business Report - Product Thumbnail Image

Allergy Drugs - Global Strategic Business Report

  • Report
  • 583 Pages
From
Loading Indicator
adroll